![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Kuros Biosciences’ MagnetOs Granules for Spine Get 510(k) Clearance
Kuros Biosciences’ MagnetOs Granules for Spine Get 510(k) Clearance
Bone graft technology company Kuros Biosciences’ MagnetOs granules have been cleared by the FDA for standalone use in spinal fusion procedures.
The FDA clearance was based on positive data from a 50-participant trial in which the granules were compared head-to-head against autograft, the gold standard for posterolateral lumbar spinal fusion.
The clearance for standalone use means that MagnetOs can be used in place of, as well as in combination with, autograft bone, the company said.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct